The American Journal of Managed Care recently caught up with Dr. Cliff Goodman, senior vice president and director of the Center for Comparative Effectiveness Research, and discussed how decision makers can best assess value as high-cost treatments hit the market. "The emergence and proliferation, […]
Thaler Talks Ways to Break Down Biases in Business World, Improve Decision Making
University of Chicago Professor Richard H. Thaler, who was awarded the Nobel Prize in 2017 for his work in research incorporating human psychology and social science into economic analysis, recently sat down with McKinsey Quarterly to break down the aspects of decision making in the corporate world […]
Califf Tapped as 2018 Walter C. Alvarez Winner
A Duke University professor and former FDA commissioner has been tapped as this year's Walter C. Alvarez Award recipient. Dr. Robert M. Califf, professor of cardiology at the Duke University of School of Medicine, will be honored as the 2018 Walter C. Alvarez Award winner. Califf is an […]
Report: FDA’s Fast Precision Drug Reviews Have Drawbacks
Researchers in an article published in Health Affairs say the Food and Drug Administration reviews precision drugs, on average, 1.7 years faster than nonprecision therapies. According to an InsideHealthPolicy report, the researchers discovered the FDA reviews also occur with less premarket […]
Finding a Placebo for Digital Health
While digital health technology has the potential to reduce health care costs, it's difficult to determine whether health-related apps deliver on their promise, Slate reports. The issue, according to the report, is developing a placebo to test the app's effectiveness. "Without placebos, we can't […]
Watch The Atlantic’s State of Care Discussion
As part of its "State of Care: Patient Access and Affordability" event, The Atlantic pulled together key perspectives to discuss the costs associated with staying healthy in the U.S. The full discussion, which was held May 23 in Washington, has been published online to watch free of […]
Podcast Focuses on Success with EHR Strategy
Relentless Health Value's Stacey Richter takes a look at how pharmaceutical companies can develop successful strategies with electronic health records. Richter, who is also the co-president of Aventria Health Group, says the information could also serve well startups and other entrepreneurs with an […]
Cultural Mindset Contributes to Decline in Number of Women in Power
Women in powerful corporate positions are getting harder to come by, according to a New York Times report. The number of female chief executives has dropped by 25 percent this year, the Times reports. It's a number already abysmally small. Just 32 women held chief executive positions at the […]
CGRP Inhibitors Could Save Billions in Migraine-Associated Costs
Migraine sufferers may have hope for a more productive livelihood, according to a recent PhRMA article. Author and Senior Director of policy and research at PhRMA Samantha Dougherty says that a new study found that if everyone who suffers from migraines used newly-emerging treatments the U.S. could […]
Blockchain Could Save Industry Costs to Maintain Directories, but Trust Among Stakeholders Key
Tools such as blockchain could potentially revolutionize the way the health care industry maintains data, but lack of trust among competitors will hinder its use, according to a Deloitte Consulting blogger. The health care industry spends a substantial sum to maintain physician records -- about […]
Elligo Health Research Acquires ePatientFinder’s Clinical Trial Exchange Platform, Practice Network
Elligo Health Research on Thursday announced its acquisition of ePatientFinder's Clinical Trial Exchange technology platform and practice network. According to a press release, the platform will bolster Elligo's trial matching process, allowing it to "streamline patient identification and […]
OM1 Announces $21 Million in Series B Financing
OM1 this week announced it had raised a new round of financing to $21 million to continue to deliver robust solutions in real-world evidence, big data and health care technology. According to a press release, the most recent round of financing was led by Polaris Partners alongside existing […]
Judge Dismisses Express Scripts Lawsuit
A judge this week ruled in favor of Express Scripts after dismissing a lawsuit alleging the pharmacy benefit manager misled shareholders, Fierce Healthcare reports. The lawsuit alleged Express Scripts inflated share prices by deceiving investors about its failing relationship with Anthem, its […]
Panel: Cultural Shift Key in Personalized Medicine
A significant cultural shift may be needed to implement a more personalized approach to medicine in the U.S., according to an International Society for Pharmacoeconomics and Outcomes Research panel. The American Journal of Managed Care reports that the panel found a lack of economic and clinical […]
Study: EHRs Could Provide Cost-Effective Means for More Complete Trial Results
Using electronic health records could have a definitive impact on the way clinical trials are conducted in the future, according to a Swansea University Medical School study. Cost and availability of resources often limit study of treatment in question beyond a two-year time frame. However the rise […]
Hernandez Outlines Barriers to RWE in Health Care Systems
The U.S. could stand to improve how it incorporates real-world evidence into the health care system, according to a report in the American Journal of Managed Care. Dr. Adrian Hernandez, vice dean for clinical research at the Duke University School of Medicine, told the AJMC that cultural and […]
FDA to Ensure Adequate Protection for Patients Under Right-To-Try
The Food and Drug Administration intends to comply with a measure that would allow patients with terminal ailments the right to access drug candidates not yet approved by the FDA, according to a Fierce Healthcare report. FDA Commissioner Dr. Scott Gottlieb said the agency would ensure patients would […]
Benchmarking Pharma’s MSL Capabilities
Are you convinced your MSL teams are keeping up with evolving market practice? The best medical science liaison (MSL) teams have made significant changes to adapt to a whole new world. The pharma companies getting the best results from their MSLs have been busy: widening their remit, embracing […]
Prescription Costs Rise for Low-Value Treatments Despite Decline in Volume
Prescription costs for low-value treatments have reportedly risen in the U.K. despite a drop in prescription numbers, according to research published by the Journal of the Royal Society of Medicine. NHS England reportedly identified low-value treatments which have been branded ineffective and too […]
AMCP Names Cynthia Reilly as Senior VP
The Academy of Managed Care Pharmacy (AMCP) announced Tuesday its appointment of Cynthia Reilly as senior vice president. According to a press release, Reilly brings 20 years of "nonprofit and pharmacy leadership" experience. "AMCP is fortunate to have someone of Cynthia's expertise and experience […]
Senator, Pharma Reportedly Working on Drug Pricing Bill
U.S. Sen. Chuck Grassley told reporters this week he's in the middle of discussions with drugmakers about potential drug-pricing legislation, The Hill reports. Grassley, who is also the Senate Judiciary Committee chairman, said the talks could facilitate Senate passage of the Creates Act, which […]
Panel Grapples with Value Assessments
A panel on Monday during ISPOR's 2018 meeting shined a spotlight on the role of value assessments in private payer coverage and formulary decision-making. Tufts Medical Center professor James Chambers, panel moderator, kicked off the discussion with an overview of how often payers cited health […]
MNCs to Benefit from China’s Open Policy
China's recent push to open its domestic pharmaceutical market on a global scale could be a significant boon for multinational corporations, The Pharma Letter reports. China's expansion could produce a number of benefits, including faster drug approvals for imported novel drugs, foreign clinical […]
Obstacles to Outcomes-Based Pricing
Outcomes-based agreements for prescription drugs continue popping up in health care talks, but experts during the World Health Care Congress cited a number of barriers holding back the payment models. One of the primary obstacles, experts say, is the lack of reliable data and regulatory […]
Quest Diagnostics Case Study Offers Cost-Saving Strategies for Employers
A recent Quest Diagnostics case study offers a three-point strategy to help self-insured employers develop more cost-effective practices. According to Quest Diagnostics, a self-insured employer with some 55,000 employees, the study, "Strategies for health plans and employers to drive cost-effective […]
3 Companies Using AI to Innovate in Health Care
The Street in an article published Friday takes a look at three companies using artificial intelligence to develop new advances in the health care sector: BioXcel Therapeutics Inc., Microsoft Corp. and Globus Medical Inc. BioXcel is using AI and big data teach to find innovative solutions in […]
Key Competencies for Value-Based Reimbursement
OPEN MINDS says it has developed an assessment tool, which has four key competencies, to help organizations guarantee their readiness for success in value-based contracting. "This tool has been used to help organizations across the country ensure their teams are prepared for value-based contracting […]
HHS Soliciting Comments from Biosimilars Stakeholders
The Department of Health and Human Services is reportedly looking for comments from biosimilars stakeholders as part of the Trump administration's to rein in drug costs. A notice for comments was published on the Federal Register Wednesday, according to the Center for Biosimilars. HHS is also […]
NPC’s Leonard Talks Value, Cancer Drug Spending
National Pharmaceutical Council President Dan Leonard in a column says this year's American Society for Clinical Oncology's Annual Meeting has much to discuss on the heels of a recent report released by an expert committee appointed by President Donald Trump. The report, "Promoting Value, […]
FDA OKs Amgen’s Migraine Drug
The Food and Drug Administration on Thursday approved Amgen's new migraine drug, Aimovig, which is used to prevent migraine headaches in adults. According to a CNBC article, the self-injected drug carries a list price of $6,900 per year ($575 per month). Amgen spokeswoman Kristen Davis said any […]
